MedTrace Logo

A Study to Assess the Safety and Performance of SurgiClot® in the Treatment of Cancellous Bone Bleeding

NCT02509208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-04-27

No results posted yet for this study

Summary

The purpose of this European study is to demonstrate the safety and performance of the SurgiClot® dressing in the treatment of cancellous bone bleeding.

Conditions

  • Cancellous Bone Bleeding

Interventions

DEVICE

SurgiClot haemostatic dressing

haemostatic dressing

Sponsors & Collaborators

  • St. Teresa Medical

    lead INDUSTRY

Principal Investigators

  • Niall Craig, MD · Aberdeen Royal Infirmary

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-01-31
Completion
2016-03-31

Countries

  • Norway
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02509208 on ClinicalTrials.gov